Though DePuy is providing some compensation to patients following the recall of the ASR devices, the compensation may not cover expenses incurred following hip replacement surgery and does not cover many diagnostic tests or blood tests that may be required to ensure a patient is healthy and to check for "metallosis."

A huge number of people who got Depuy ASR™ Hip Replacements that are now being recalled suffer from some pretty awful symptoms. For many, it starts with muscle fatigue, but quickly deteriorates and causes constant hip, leg, and back pain.

A member of the Johnson & Johnson Family of Companies, DePuy Orthopaedics recently announced a worldwide recall of the company's ASR XL Acetabular Hip System and the ASR Hip Resurfacing System, used in more than 90,000 hip replacement surgeries since the devices were introduced in 2003.

In late 2009, DePuy Orthopedics, a division of Johnson & Johnson, announced its plan to phase out sales of the product worldwide by the end of 2010, but not before the ASR had been implanted in thousands of people. Approximately 250,000 people in the US alone receive hip replacement implants every year and about one-third of those receive metal-on-metal implants. Of those that receive the DePuy ASR hip replacement, twelve percent, or approximately 1 in 8 patients, will require hip revision surge

It was during the year 2005 that the FDA gave a special approval to DePuy Orthaepedics to promote their ASR devices without any clinical trials.

This URL was also folkd by: